Femasys (FEMY) Cash from Operations Growth (1y) (2021 - 2026)
Femasys (FEMY) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -28.74% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 0.99% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -15.62% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 262.94% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 34.32% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 90.02% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -4.50% |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 | 9.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.05% |
| Dec 31, 2025 | 17.53% |
| Sep 30, 2025 | 1.59% |
| Jun 30, 2025 | -0.60% |
| Mar 31, 2025 | -4.31% |
| Dec 31, 2024 | -67.15% |
| Sep 30, 2024 | -91.71% |
| Jun 30, 2024 | -57.84% |
| Mar 31, 2024 | -72.54% |
| Dec 31, 2023 | -5.86% |
| Sep 30, 2023 | -4.60% |
| Jun 30, 2023 | -15.18% |
| Mar 31, 2023 | 3.86% |
| Dec 31, 2022 | -27.58% |
| Sep 30, 2022 | -51.55% |
| Jun 30, 2022 | 12.53% |
| Mar 31, 2022 | -137.28% |
| Dec 31, 2021 | -76.86% |
| Sep 30, 2021 | -109.71% |